A MILTON Keynes-based corporate finance expert has helped broker an international multi-million pound deal to create one of the world’s largest healthcare and pharmaceutical event management companies.
Precision Corporate Finance based in Old Wolverton, has advised World Events Group Limited a Yorkshire-based event management specialist that has been bought by United Drug plc for £13.5 million.
World Events was advised by Neil Ackroyd of Precision Corporate Finance and Daniel O’Connell of lawyers Kerman and Co.
The Milton Keynes-based corporate finance boutique and the London law firm are both specialists in this type of deal. They have now advised on three major deals in the marketing and event management sector in the last 10 years; TMO acquired by BI in 2001 and Universal CIT sold to UD in 2008 making them eminently qualified to guide the deal to a successful legal completion.
Neil Ackroyd, managing director of Precision said: “This is a significant deal for the sector and establishes Precision as the leading advisor in the marketing and event management sector.”
The deal will see World Events Group join United Drug, an Irish public company, dual-listed on the Irish and UK stock exchanges. It owns a growing number of companies operating primarily in the UK, Ireland, and the USA. All of its businesses are strongly allied to the pharmaceutical and healthcare sectors.
World Events has offices in the US, Asia and throughout Europe. It will be integrated into UD’s Contract Sales and Marketing Services division.